Page last updated: 2024-11-05

acetoacetanilide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-phenylacetoacetamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7592
CHEMBL ID1604429
SCHEMBL ID14914
MeSH IDM0159619

Synonyms (87)

Synonym
BB 0240786
3-oxo-n-phenyl-butyramide
acetoacetic anilide
.alpha.-acetylacetanilide
nsc-2656
acetoacetylaniline
acetylacetanilide
102-01-2
acetoacetanilide
.beta.-ketobutyranilide
wln: 1v1vmr
3-oxo-n-phenylbutanamide
nsc2656
acetoacetylaminobenzene
acetanilide, 2-acetyl-
n-(acetylacetyl)aniline
butanamide, 3-oxo-n-phenyl-
acetoacetamidobenzene
.alpha.-acetyl-n-phenylacetamide
n-phenylacetoacetamide
1-(phenylcarbamoyl)-2-propanone
usaf ek-1239
acetoacetic acid anilide
inchi=1/c10h11no2/c1-8(12)7-10(13)11-9-5-3-2-4-6-9/h2-6h,7h2,1h3,(h,11,13
3-oxo-n-phenyl-butanamide
NCGC00091590-01
nsc 2656
butanoic acid, 3-oxo-, amide, n-phenyl-
ai3-00854
beta-ketobutyranilide
hsdb 2669
ccris 4534
einecs 202-996-4
((acetoacetyl)amino)benzene
acetoacetanilid
alpha-acetyl-n-phenylacetamide
anilid kyseliny acetoctove [czech]
STK301287
acetoacetanilide, >=98%
acetoacetanilide, >=99.5%
NCGC00091590-02
A0046
FT-0695963
AKOS000119678
NCGC00091590-03
CHEMBL1604429
86349-51-1
cas-102-01-2
tox21_303279
dtxcid504397
dtxsid0024397 ,
NCGC00257189-01
NCGC00258956-01
tox21_201405
unii-w35jb9py3x
anilid kyseliny acetoctove
w35jb9py3x ,
ec 202-996-4
FT-0621767
butanamide, 3-oxo-n-phenyl-, labeled with carbon-14
3-oxo-n-phenylbutyramide
acetoacetanilide [mi]
.alpha.-ketobutyranilide
n-(acetoacetyl)aniline
1-(phenylamino)-1,3-1-(phenylcarbamoyl)-2-propanone
4-(phenylamino)-2,4-butanedione
1-(phenylamino)-1,3-butanedione
n-phenyl-3-oxobutanamide
n-phenylacetylacetamide
acetoacetanilide [hsdb]
SCHEMBL14914
2-acetylacetanilide
n-phenyl-3-ketobutanamide
alpha-acetyl-n-phenyl-acetamide
acetoacetonilide
[(acetoacetyl)amino]benzene
W-108892
F0001-0065
mfcd00008780
Z56968279
acetoacetailide
n-acetoacetanilide
Q15720542
EN300-17592
STR00568
acetessigsa currencyureanilid
F86391
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency43.57010.000221.22318,912.5098AID1259381; AID743053; AID743054
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.00250.000214.376460.0339AID588532
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency28.94250.001530.607315,848.9004AID1224841; AID1224842
pregnane X nuclear receptorHomo sapiens (human)Potency68.51990.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency34.80540.000229.305416,493.5996AID588513; AID743069; AID743075; AID743079
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.31150.001628.015177.1139AID1224843
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency14.33720.000323.4451159.6830AID743065; AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency55.89850.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID548113Inhibition of Trypanosoma cruzi triosephosphate isomerase at 400 uM after 2 hrs2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
AID548110Antiparasitic activity against Trypanosoma cruzi T2 epimastigotes assessed as growth inhibition at 25 uM after 5 days2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
AID548108Selectivity for Trypanosoma cruzi triosephosphate isomerase over human triosephosphate isomerase2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
AID548112Inhibition of Trypanosoma cruzi triosephosphate isomerase at 100 uM after 2 hrs2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's9 (64.29)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.03 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index83.75 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]